Back to Results
First PageMeta Content
Medicinal chemistry / Cancer research / Clinical research / Pharmacology / Hsp90 inhibitors / Drug discovery / Drug design / Hsp90 / Protein kinase / Pharmaceutical sciences / Medicine / Biology


Document Date: 2013-10-01 08:48:56

Open Document

File Size: 181,62 KB

Share Result on Facebook

Company

Novartis / Vernalis Ltd / Wellcome Trust / The Institute / /

Currency

pence / /

Event

Business Partnership / FDA Phase / /

Facility

The Institute’s Cancer Research UK Centre / The Institute / Cancer Research UK Centre / The Institute of Cancer Research / /

IndustryTerm

synthetic chemical compound / chemical constitution / chemical groups / chemical starting point / chemical starting points / Cancer therapeutics / lipophilic / chemical compounds / lipophilic aryl / chemical series / chemical structure / synthetic chemical / /

MedicalCondition

Cancer / tumour / tumours / /

MedicalTreatment

Cancer therapeutics / /

Organization

Centre for Cancer Therapeutics / Cancer Research UK Centre for Cancer Therapeutics / Institute of Cancer Research / /

Person

David Barford / Laurence Pearl / Wynne Aherne / Rob Van Montfort / Ian Collins / Paul Workman / Ted McDonald / Michelle Garrett / /

Position

CCHEM FRSC Leader of Medicinal Chemistry Team / Professor / Workman / /

Product

adenosine / Other drug / /

PublishedMedium

Cancer Research / /

Technology

pharmacokinetics / drug discovery / X-ray / drug design / /

SocialTag